日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HIV-1 drug resistance among HIV/HCV co-infected patients with treatment failure in Yunnan, southwestern China: a cross-sectional study

中国西南云南省HIV/HCV合并感染治疗失败患者的HIV-1耐药性:一项横断面研究

Li, Huan; Ma, Xiaobo; Li, Ya; He, Chenglu; Zou, Fang; Kang, Xilin; Zhong, Min

MPC2 Overexpression Drives Mitochondrial Oxidative Phosphorylation and Promotes Progression in Diffuse Large B-Cell Lymphoma.

MPC2 过表达驱动线粒体氧化磷酸化并促进弥漫性大 B 细胞淋巴瘤的进展。

Wu Haoneng, Zhao Qiuran, Ma Xiaobo, Zhao Ying, Wang Qing, Bai Jinguang, Huang Songling

Stem cell-based strategies for intervertebral disc regeneration in degenerative microenvironments: challenges and solutions

干细胞在退行性微环境下椎间盘再生中的应用:挑战与解决方案

Wang, Honglin; Xu, Aoshuang; Hua, Wei; Mao, Junling; Zhang, Jiyao; Ma, Xiaobo; Lu, Lin

Intratympanic dexamethasone microcrystals/lidocaine-loaded PLGA non-spherical microparticles for local drug delivery to the inner ear

用于内耳局部药物递送的鼓室内地塞米松微晶/利多卡因负载的PLGA非球形微粒

Wang, Dongcheng; Zhang, Xin; Wang, Zhen; Ran, Cheng; Hao, Jia; Ma, Xiaobo; Wang, Minghui; Zhou, Zhimin

The whole organization system management mode in the treatment of COVID-19

新冠肺炎治疗中的全组织系统管理模式

Yang, Zhenhua; Ma, Xiaobo; Zhu, Weiyi

Case Report: Clinical metastasis characteristics of lung adenosquamous carcinoma with ROS1 rearrangement

病例报告:ROS1重排肺腺鳞癌的临床转移特征

Chen, Xi; Ma, Kewei; Ma, Xiaobo; Zhu, Wenhao; Liu, Bo; Duan, Xiumei; Xu, Yinghui

A high throughput strategy for traditional Chinese medicine active compound screening based on Raman spectroscopy

基于拉曼光谱的高通量中药活性成分筛选策略

Tian, Mengyin; Ma, Xiaobo; Li, Yuandong; Zang, Hengchang; Li, Lian

Dual-modal overcoming of physical barriers for improved photodynamic cancer therapy via soft organosilica nanocapsules

利用软性有机硅纳米胶囊双模式克服物理障碍,改善光动力癌症治疗

Lu, Wei; Li, Yang; Zhang, Xiaojun; Wang, Ning; Chen, Dong; Zhao, Yatong; Li, Guang; Shi, Xuzhi; Ma, Xiaobo; Su, Xiaodan; Wang, Feng; Shu, Chuqiang; Chen, Kun

Efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy in potentially resectable stage IIIA/IIIB non-small cell lung cancer: Neo-Pre-IC, a single-arm phase 2 trial

新辅助PD-1抑制剂(信迪利单抗)联合化疗治疗潜在可切除的IIIA/IIIB期非小细胞肺癌的疗效和安全性:Neo-Pre-IC,一项单臂II期试验

Sun, Chao; Wang, Xu; Xu, Yinghui; Shao, Guoguang; Chen, Xi; Liu, Yunpeng; Zhang, Peng; Lin, Xingyu; Ma, Xiaobo; Qiu, Shi; He, Hua; Yang, Zhiguang; Ma, Kewei

Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study

新辅助化疗联合免疫疗法和化疗治疗潜在可切除的IIIA/IIIB期非小细胞肺癌患者的疗效和安全性:一项回顾性研究

Wang, Yuchen; Ma, Xiaobo; Ma, Kewei; Chen, Xi; He, Hua; Zhao, Xiangye; Fan, Mengge; Xu, Yinghui